Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-01-09
2007-01-09
Minnifield, N. M. (Department: 1645)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S365000, C435S366000, C435S007210
Reexamination Certificate
active
10399489
ABSTRACT:
The present invention involves an assay system and method of selecting compounds useful in the treatment of bladder instability and related bladder conditions through the activation of KCNQ potassium channels in the bladder smooth muscle.
REFERENCES:
patent: 6133275 (2000-10-01), Ehrlich et al.
patent: 6277978 (2001-08-01), Keating et al.
patent: 6348486 (2002-02-01), Argentieri et al.
patent: 6403360 (2002-06-01), Blanar et al.
patent: 6413719 (2002-07-01), Singh et al.
patent: 6455568 (2002-09-01), Jenkins et al.
patent: 6582913 (2003-06-01), Keating et al.
patent: 6613786 (2003-09-01), Hewawasam et al.
patent: 6617131 (2003-09-01), Steinmeyer et al.
patent: 6635660 (2003-10-01), Jenkins et al.
patent: 6767736 (2004-07-01), Hu et al.
patent: 6794161 (2004-09-01), Jentsch
patent: 2002/0137746 (2002-09-01), Carl et al.
patent: 2004/0197825 (2004-10-01), Karicheti et al.
patent: 2005/0037460 (2005-02-01), Jentsch
patent: 2005/0059823 (2005-03-01), McNaughton-Smith et al.
patent: 2005/0101004 (2005-05-01), Argentieri et al.
patent: WO 00/44786 (2000-08-01), None
patent: 1326597 (2005-12-01), None
patent: WO 99/07832 (1999-02-01), None
patent: WO 99/21875 (1999-05-01), None
patent: WO 00/44786 (2000-08-01), None
patent: WO 01/01970 (2001-01-01), None
patent: WO 02/32419 (2002-04-01), None
MedLine Plus Medical Encyclopedia, A.D.A.M., Inc. online last update May 3, 2002.
Kubisch et al, Cell, 1999, 96/3:437-446.
Hewawasam et al, Bioorganic and Medicinal Chemistry Letters, 2002, 12:1117-1120.
Dmochowski et al, Urology, 2000, 56/Suppl. 6A:41-49.
Andersson, Best Practice and Research Clinical Obsterics and Gynaecology, 2000, 14/2:291-313 Abstract Only.
Wang et al, Science, 1998, 282:1890-1893.
Smith et al, J. Neuroscience, 2001, 21/4:1096-1103.
Butera et al, Bioorganic and Medicinal Chemistry Letters, 2001, 11:2093-2097.
Woods et al, J. Urology, 2001, 166/3:1142-1147 Abstract Only.
Gilbert et al, J. Medicinal Chemistry, 2000, 43/6:1203-1214 Abstract Only.
Butera et al, J. Medicinal Chemistry, 2000, 43/6:1187-1202 Abstract Only.
Wein et al, Urology, 1998, 51/2A Suppl.:43-47 Abstract Only.
Levin et al, Pharmacology, 1992, 45/1:1-8 Abstract Only.
Butera et al, Drugs of the Future, 2000, 25/3:239-245 Abstract Only.
Wojdan et al, J. Pharmacology and Experimental Therapeutics, 1999, 289/3:1410-1418 Abstract Only.
Antane et al, Book of Abstracts, 218thACS National Meeting, New Orleans, Aug. 22-26, 1999.
Sudoh et al, J. Autonomic Pharmacology, 1997, 17/2:91-96 Abstract Only.
Gutman et al, Pharmacological Reviews, 2003, 65/4:583-586.
Andersson, Urology, 2000, 55/Suppl 5A:51-57.
Thorneloe et al, J. Physiol., 2003, 549.1:65-74.
Wein, Exp. Opin. Invest. Drugs, 2001, 10/1:65-83.
Michel, Urologe A., Jun. 2003, 42/6:807-811 abstract only.
Butera et al, Bioorganic and Medicinal Chemistry Letters, 2005, 15:2495-2501.
Meredith et al, JBC, Aug. 27, 2004, 279/35:36746-36752.
Wickenden et al, Characterization of the KCNQ5/Q3 potassium channels expressed in mammalian cells. Dr. J. Pharmacol., 2001, 132:381-384.
Main et al, Molecular Pharmacology, 2000, 58:253-262.
Rundfeldt et al, Neuroscience Letters, 2000, 282:73-76.
Hashitani et al, J. Physiology, 2000, 524.2:565-579.
Rogawski, Trends in Neuroscience, 2000, 23:393-398.
Herrera et al, Am. J. Physiol. Cell Physiol., 2001, 280:C481-C490.
Shapiro et al, J. Neuroscience, Mar. 1, 2000, 20/5:1710-1721.
Wickenden et al, Molecular Pharmacology, 2000, 58/3:591-600.
Susumu et al., Japanese J. Pharm. (2000) 82:Suppl. 1:135P, 73rdAnnual Meeting of the Japanese Pharmacological Society, Yokohama, Japan, Mar. 23-25, 2000. Abstract.
Sugimoto et al., J. Membrane Biol. (1990) 113:1:39-48 and BIOSYS Online! Biosciences Information Service, Phila. PA (1990) Database accession No. PREV199089080542. Abstract.
Huber et al., Am. J. Physio1. (2000) 279:1(part 2):F65-F76.
Vallon et al., J. Am. Soc. Nephrol. (2001) 12:10:2003-2011.
Tomoyuki et al. Japanese J. Physiol. (2002) 52:1:31-39 and BIOSYS Online!Biosciences Information Service, Phila. PA (2002) Database accession No. PREV200200284496. Abstract.
Sheldon, J. H. et al., (2002) ASPET-Ray Fuller Symposium, Lower Urinary Tract Disorders: Physiology, Pharmacology & Therapeutic Approaches, San Francisco, CA, Jul. 2002.
Argentieri Thomas M.
Sheldon Jeffrey H.
Darby & Darby
Minnifield N. M.
Wyeth
LandOfFree
Methods of selecting compounds for modulation of bladder... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of selecting compounds for modulation of bladder..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of selecting compounds for modulation of bladder... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3765595